The Semont-Plus Maneuver or the Epley Maneuver in Posterior Canal Benign Paroxysmal Positional Vertigo: A Randomized Clinical Study
- PMID: 37358870
- PMCID: PMC10425825
- DOI: 10.1001/jamaneurol.2023.1408
The Semont-Plus Maneuver or the Epley Maneuver in Posterior Canal Benign Paroxysmal Positional Vertigo: A Randomized Clinical Study
Abstract
Importance: Questions remain concerning treatment efficacy for the common condition of benign paroxysmal positional vertigo (BPPV).
Objective: To compare the effectiveness of the Semont-plus maneuver (SM-plus) and the Epley maneuver (EM) for treatment of posterior canal benign paroxysmal positional vertigo (pcBPPV) canalolithiasis.
Design, setting, and participants: This prospective randomized clinical trial was performed at 3 national referral centers (in Munich, Germany; Siena, Italy; and Bruges, Belgium) over 2 years, with a follow-up to 4 weeks after the initial examination. Recruitment took place from June 1, 2020, until March 10, 2022. Patients were selected randomly during routine outpatient care after being referred to 1 of the 3 centers. Two hundred fifty-three patients were assessed for eligibility. After consideration of the exclusion criteria as well as informed consent, 56 patients were excluded and 2 declined to participate, with 195 participants included in the final analysis. The analysis was prespecified and per-protocol.
Interventions: After being randomized to the SM-plus or the EM group, patients received 1 initial maneuver from a physician, then subsequently performed self-maneuvers at home 3 times in the morning, 3 times at noon, and 3 times in the evening.
Main outcome and measures: Patients had to document whether they could provoke positional vertigo every morning. The primary end point was the number of days until no positional vertigo could be induced on 3 consecutive mornings. The secondary end point was the effect of the single maneuver performed by the physician.
Results: Of the 195 participants included in the analysis, the mean (SD) age was 62.6 (13.9) years, and 125 (64.1%) were women. The mean (SD) time until no positional vertigo attacks could be induced in the SM-plus group was 2.0 (1.6) days (median, 1 [range, 1-8] day; 95% CI, 1.64-2.28 days); in the EM group, 3.3 (3.6) days (median, 2 [range, 1-20] days; 95% CI, 2.62-4.06 days) (P = .01; α = .05, 2-tailed Mann-Whitney test). For the secondary end point (effect of a single maneuver), no significant difference was detected (67 of 98 [68.4%] vs 61 of 97 [62.9%]; P = .42; α = .05). No serious adverse event was detected with both maneuvers. Nineteen patients (19.6%) in the EM group and 24 (24.5%) in the SM-plus group experienced relevant nausea.
Conclusions and relevance: The SM-plus self-maneuver is superior to the EM self-maneuver in terms of the number of days until recovery in pcBPPV.
Trial registration: ClinicalTrials.gov Identifier: NCT05853328.
Conflict of interest statement
Figures
Similar articles
-
Epley and Semont maneuvers for posterior canal benign paroxysmal positional vertigo: A network meta-analysis.Laryngoscope. 2016 Apr;126(4):951-5. doi: 10.1002/lary.25688. Epub 2015 Sep 25. Laryngoscope. 2016. PMID: 26403977
-
A multicenter randomized double-blind study: comparison of the Epley, Semont, and sham maneuvers for the treatment of posterior canal benign paroxysmal positional vertigo.Audiol Neurootol. 2014;19(5):336-41. doi: 10.1159/000365438. Epub 2014 Nov 1. Audiol Neurootol. 2014. PMID: 25377361 Clinical Trial.
-
[A randomized controlled trial on short-term efficacy of the modified Semont maneuver for the treatment of posterior canal benign paroxysmal positional vertigo].Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Oct 5;31(19):1468-1472. doi: 10.13201/j.issn.1001-1781.2017.19.002. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017. PMID: 29798096 Clinical Trial. Chinese.
-
Benign paroxysmal positional vertigo.Auris Nasus Larynx. 2022 Oct;49(5):737-747. doi: 10.1016/j.anl.2022.03.012. Epub 2022 Apr 3. Auris Nasus Larynx. 2022. PMID: 35387740 Review.
-
Semont maneuver for posterior canal benign paroxysmal positional vertigo: a systematic review of randomized controlled trials.Eur Arch Otorhinolaryngol. 2024 Aug;281(8):3985-3999. doi: 10.1007/s00405-024-08586-0. Epub 2024 Mar 26. Eur Arch Otorhinolaryngol. 2024. PMID: 38530461 Review.
Cited by
-
Treating benign paroxysmal positional vertigo in acute traumatic brain injury: a prospective, randomised clinical trial assessing safety, feasibility, and efficacy.BMJ Neurol Open. 2024 May 28;6(1):e000598. doi: 10.1136/bmjno-2023-000598. eCollection 2024. BMJ Neurol Open. 2024. PMID: 38818242 Free PMC article.
-
To compare the recovery rates of modified Epley's against Semont's manoeuvres in patients with posterior canal benign paroxysmal positional vertigo: a randomized clinical trial.Eur Arch Otorhinolaryngol. 2024 Sep;281(9):4641-4648. doi: 10.1007/s00405-024-08657-2. Epub 2024 Apr 23. Eur Arch Otorhinolaryngol. 2024. PMID: 38652297 Clinical Trial.
References
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
